Mutations in the human laminin beta2 (LAMB2) gene and the associated phenotypic spectrum

Verena Matejas, Bernward Hinkes, Faisal Alkandari, Lihadh Al-Gazali, Ellen Annexstad, Mehmet B. Aytac, Margaret Barrow, Kveta Bláhová, Detlef Bockenhauer, Hae Il Cheong, Iwona Maruniak-Chudek, Pierre Cochat, Jörg Dötsch, Priya Gajjar, Raoul C. Hennekam, Françoise Janssen, Mikhail Kagan, Ariana Kariminejad, Markus J. Kemper, Jens KoenigJillene Kogan, Hester Y. Kroes, Eberhard Kuwertz-Bröking, Amy F. Lewanda, Ana Medeira, Jutta Muscheites, Patrick Niaudet, Michel Pierson, Anand Saggar, Laurie Seaver, Mohnish Suri, Alexey Tsygin, Elke Wühl, Aleksandra Zurowska, Steffen Uebe, Friedhelm Hildebrandt, Corinne Antignac, Martin Zenker

Research output: Contribution to journalArticleAcademicpeer-review

164 Citations (Scopus)

Abstract

Mutations of LAMB2 typically cause autosomal recessive Pierson syndrome, a disorder characterized by congenital nephrotic syndrome, ocular and neurologic abnormalities, but may occasionally be associated with milder or oligosymptomatic disease variants. LAMB2 encodes the basement membrane protein laminin beta2, which is incorporated in specific heterotrimeric laminin isoforms and has an expression pattern corresponding to the pattern of organ manifestations in Pierson syndrome. Herein we review all previously reported and several novel LAMB2 mutations in relation to the associated phenotype in patients from 39 unrelated families. The majority of disease-causing LAMB2 mutations are truncating, consistent with the hypothesis that loss of laminin beta2 function is the molecular basis of Pierson syndrome. Although truncating mutations are distributed across the entire gene, missense mutations are clearly clustered in the N-terminal LN domain, which is important for intermolecular interactions. There is an association of missense mutations and small in frame deletions with a higher mean age at onset of renal disease and with absence of neurologic abnormalities, thus suggesting that at least some of these may represent hypomorphic alleles. Nevertheless, genotype alone does not appear to explain the full range of clinical variability, and therefore hitherto unidentified modifiers are likely to exist
Original languageEnglish
Pages (from-to)992-1002
JournalHuman mutation
Volume31
Issue number9
DOIs
Publication statusPublished - 2010

Cite this